Validation of 2 Syncope Risk Scores and Comparison With Physician Risk Estimation - Summary - MDSpire

Validation of 2 Syncope Risk Scores and Comparison With Physician Risk Estimation

  • By

  • Edward H. Suh

  • Carolyn Winskill

  • Dana L. Sacco

  • John DeAngelis

  • Daniel K. Nishijima

  • Jonathan Schimmel

  • Alan B. Storrow

  • Nancy E. Wood

  • Venkatesh Thiruganasambandamoorthy

  • Christopher W. Baugh

  • Robert E. Weiss

  • Marc A. Probst

  • May 19, 2026

  • 0 min

Share

Objective:

To prospectively validate the Canadian Syncope Risk Score (CSRS) and FAINT score for predicting 30-day serious outcomes in patients aged 40 and older presenting with syncope or presyncope, and to compare their performance with physician risk evaluations.

Key Findings:
  • CSRS and FAINT score were validated for predicting serious outcomes within 30 days.
  • Physician risk estimates were compared to the scores for performance evaluation.
  • The study aimed for a sample size of 1232 patients to ensure adequate power for statistical analysis.
Interpretation:

The validation of CSRS and FAINT score could enhance risk stratification and management of patients with syncope and presyncope, potentially reducing unnecessary hospitalizations.

Limitations:
  • The study was limited to patients aged 40 and older.
  • Results may not be generalizable to all emergency department populations.
Conclusion:

Prospective validation of CSRS and FAINT score may provide objective tools for assessing risk in syncope patients, improving clinical decision-making.

Original Source(s)

Related Content